Concept information
Preferred term
Alemtuzumab
Type
-
Topical Descriptor
Broader concept
Entry terms
- Campath
- Campath 1G
- Campath 1H
- Campath 1M
- Lemtrada
- MabCambath
Scope note
- An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
History note
- 2018 (1995)
In other languages
-
Finnish
-
Swedish
-
Lemtrada
URI
http://www.yso.fi/onto/mesh/D000074323
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}